| Unfavorable outcome | ||||||
| Characteristics | n | n (%) | OR (95% CI) | P value | aOR (95% CI) | P value |
| Sex |
|
|
|
|
|
|
| Female | 354 | 59 (6.22) | Reference | - | Reference | - |
| Male | 534 | 113 (11.9) | 1.17 (0.83 - 1.66) | 0.363 | 1.54 (0.99 - 2.39) | 0.055 |
| Age (years) |
|
|
|
|
|
|
| <25 | 274 | 42 (4.4) | Reference | - | Reference | - |
| 25 - 44 | 488 | 97 (10.2) | 1.37 (0.92 - 2.03) | 0.12 | 1.04 (0.65 - 1.66) | 0.862 |
| ≥45 | 185 | 33 (3.5) | 1.19 (0.72 - 1.96) | 0.49 | 0.67 (0.35 - 1.26) | 0.211 |
| BMI |
|
|
|
|
|
|
| <18.5 | 370 | 52 (5.5) | Reference | - | Reference | - |
| 18.5 - 24.9 | 551 | 117 (12.3) | 1.65 (1.15 - 2.36) | 0.06 | 1.48 (0.95 - 2.30) | 0.084 |
| ≥25 | 27 | 3 (0.3) |
|
|
|
|
| TB history |
|
|
|
|
|
|
| No | 449 | 108 (11.4) | Reference | - | Reference |
|
| Yes | 499 | 64 (6.7) | 0.46 (0.33 - 0.65) | 0.000 | 0.58 (0.39 - 0.88) | 0.01 |
| VIH Status |
|
|
|
|
|
|
| Negative | 830 | 130 (13.7) | Reference | - | Reference | - |
| Positive | 118 | 42 (4.4) | 2.42 (1.94 - 4.51) | 0.000 | 2.02 (1.70 - 5.00) | 0.000 |
| Delay |
|
|
|
|
|
|
| <7 | 101 | 32 (3.4) | Reference | - | Reference |
|
| 7 - 30 | 588 | 81 (8.5) | 0.34 (0.21 - 0.57) | 0.000 | 0.49 (0.27 - 0.89) | 0.02 |
| >30 | 259 | 34 (5.6) | 0.64 (0.38 - 1.05) | 0.082 | 0.98 (0.52 - 1.85) | 0.951 |
| Lesions extent |
|
|
|
|
|
|
| <50% | 941 | 170 (17.9) | Reference | - | Reference |
|
| ≥50% | 7 | 2 (0.2) | 1.81 (0.35 - 9.43) | 0.479 | 2.51 (0.38 - 16.61) | 0.341 |
| Adverse Events (3 - 4) |
|
|
|
|
|
|
| No | 855 | 162 (17.1) | Reference | - | Reference | - |
| Yes | 93 | 10 (1.6) | 0.52 (0.26 - 1.02) | 0.055 | 0.63 (0.29 - 1.37) | 0.243 |